Related Experiment Video
Updated: Nov 24, 2025

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
[Risk factors associated with valvular calcification in patients with chronic kidney disease. Analysis of NEFRONA
Lidia Martínez Fernández1, J Emilio Sánchez-Alvarez2, César Morís de la Tassa1
1Hospital Universitario Central de Asturias, Oviedo, Asturias, España.
Insights
Valvular calcification is common in chronic kidney disease (CKD) patients and progresses over two years. Risk factors for mitral calcification include age, ABI, and CaxP; aortic calcification is linked to age, phosphorus, and carotid plaque.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Patients with chronic kidney disease (CKD) face elevated risks of cardiovascular morbidity and mortality.
- Subclinical cardiac structural changes, particularly valvular calcification, are significant prognostic indicators in CKD.
- Understanding the prevalence and progression of valvular calcification is crucial for managing cardiovascular risk in CKD.
Purpose of the Study:
- To determine the prevalence and 24-month evolution of aortic and mitral valve calcification in CKD patients.
- To investigate the association between valvular calcification and various cardiovascular risk factors, including estimated glomerular filtration rate (eGFR).
- To identify patient subgroups at higher risk for developing valvular calcification.
Main Methods:
- A cohort of 397 CKD patients from the NEFRONA study was analyzed.
- Echocardiograms were performed at baseline and 24 months to assess aortic and mitral valve calcification.
- Statistical analyses examined associations between calcification and risk factors like age, eGFR, ankle-brachial index (ABI), calcium-phosphorus product (CaxP), and carotid plaque area.
Main Results:
- A significant prevalence of valvular calcification was observed in CKD patients without prior cardiovascular disease.
- Over 24 months, there was a progression in valvular calcification and carotid plaque area, independent of eGFR.
- Mitral calcification was associated with older age, higher ABI, and CaxP at baseline.
- Aortic calcification was associated with older age, higher phosphorus levels, and larger carotid plaque area at baseline.
Conclusions:
- Valvular calcification is prevalent and progressive in CKD patients, even without known cardiovascular disease.
- Progression of valvular calcification occurs independently of eGFR over a two-year period.
- Identifying patients with higher risk factors (age, ABI, CaxP, phosphorus, carotid plaque) can guide intensified monitoring to prevent cardiovascular events.
Introduction:
Patients with chronic kidney disease (CKD) are at high risk of cardiovascular morbidity and mortality. Subclinical cardiac structural alterations have prognostic value in these patients. The aim was to analyse the prevalence of valvular calcification, the evolution and the relationship with different risk factors.
Material And Methods:
Part of the sample of the NEFRONA study was randomly selected. Aortic and mitral valve calcification were analysed in echocardiograms performed at the baseline visit and at 24 months.
Results:
We included 397 patients, the estimated basal glomerular filtrate (eGFR) was 33ml/min with significant decrease to 30.9ml/min. There was an increase in the area of carotid and femoral plaque, as well as an increase in patients with aortic and mitral calcification at 24 months. A positive association of mitral calcification at 24 months with age, ankle-brachial index (ABI) and calcium-phosphorus product (CaxP) at baseline visit was observed, without association with eGFR. Aortic calcification at 24 months was positively associated with age, phosphorous and total carotid plaque area at baseline, with no relationship to eGFR.
Conclusions:
A significant prevalence of valvular calcification was observed in patients with CKD without known cardiovascular disease.Two-year progression was observed independently of the eGFR. Patients with higher risk of mitral valve calcification were those with older age, higher ABI and CaxP product. Patients with a higher risk of aortic calcification were those with older age, higher phosphorous levels and larger area of carotid plaque. Identifying these higher risk patients would help to avoid future cardiovascular events intensifying follow-ups.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Nephrons
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention

